Paris-based Exeliom Biosciences, a clinical-stage BioTech company developing new therapies in immuno-oncology and immuno-inflammation, today announced the completion of a…
Read More

Paris-based Exeliom Biosciences, a clinical-stage BioTech company developing new therapies in immuno-oncology and immuno-inflammation, today announced the completion of a…
Read More
FREMONT, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today…
Read More
Irish Immunotherapy startup LIfT BioSciences, has secured a €12 million grant from Ireland’s Disruptive Technologies Innovation Fund (DTIF) to support…
Read More